Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-21-023880

Director sold 10,000 shares at an average $126.61 ($1,266,118)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2021-06-11 Sale −5,427 $125.62 $681,753 24,948 D: show line 1 in the form
Bolzon Bradley J PhD Director 2021-06-11 Sale −1,918 $126.59 $242,808 23,030 D: show line 2 in the form
Bolzon Bradley J PhD Director 2021-06-11 Sale −800 $127.88 $102,307 22,230 D: show line 3 in the form
Bolzon Bradley J PhD Director 2021-06-11 Sale −1,100 $128.65 $141,517 21,130 D: show line 4 in the form
Bolzon Bradley J PhD Director 2021-06-11 Sale −755 $129.45 $97,733 20,375 D: show line 5 in the form
Open-market sales · 10,000 sh · avg $126.61 · $1,266,118
Loading xslF345X03/doc4.xml…